1 Study Coverage
    1.1 Live Vaccines Product Introduction
    1.2 Market by Type
        1.2.1 Global Live Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Monovalent Live Vaccines
        1.2.3 Multivalent Live Vaccines
    1.3 Market by Application
        1.3.1 Global Live Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Adults
        1.3.3 Children
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Live Vaccines Sales Estimates and Forecasts 2017-2028
    2.2 Global Live Vaccines Revenue Estimates and Forecasts 2017-2028
    2.3 Global Live Vaccines Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Live Vaccines Sales by Region
        2.4.1 Global Live Vaccines Sales by Region (2017-2022)
        2.4.2 Global Sales Live Vaccines by Region (2023-2028)
    2.5 Global Live Vaccines Revenue by Region
        2.5.1 Global Live Vaccines Revenue by Region (2017-2022)
        2.5.2 Global Live Vaccines Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Live Vaccines Sales by Manufacturers
        3.1.1 Global Top Live Vaccines Manufacturers by Sales (2017-2022)
        3.1.2 Global Live Vaccines Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Live Vaccines in 2021
    3.2 Global Live Vaccines Revenue by Manufacturers
        3.2.1 Global Live Vaccines Revenue by Manufacturers (2017-2022)
        3.2.2 Global Live Vaccines Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Live Vaccines Revenue in 2021
    3.3 Global Live Vaccines Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Live Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Live Vaccines Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Live Vaccines Sales by Type
        4.1.1 Global Live Vaccines Historical Sales by Type (2017-2022)
        4.1.2 Global Live Vaccines Forecasted Sales by Type (2023-2028)
        4.1.3 Global Live Vaccines Sales Market Share by Type (2017-2028)
    4.2 Global Live Vaccines Revenue by Type
        4.2.1 Global Live Vaccines Historical Revenue by Type (2017-2022)
        4.2.2 Global Live Vaccines Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Live Vaccines Revenue Market Share by Type (2017-2028)
    4.3 Global Live Vaccines Price by Type
        4.3.1 Global Live Vaccines Price by Type (2017-2022)
        4.3.2 Global Live Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Live Vaccines Sales by Application
        5.1.1 Global Live Vaccines Historical Sales by Application (2017-2022)
        5.1.2 Global Live Vaccines Forecasted Sales by Application (2023-2028)
        5.1.3 Global Live Vaccines Sales Market Share by Application (2017-2028)
    5.2 Global Live Vaccines Revenue by Application
        5.2.1 Global Live Vaccines Historical Revenue by Application (2017-2022)
        5.2.2 Global Live Vaccines Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Live Vaccines Revenue Market Share by Application (2017-2028)
    5.3 Global Live Vaccines Price by Application
        5.3.1 Global Live Vaccines Price by Application (2017-2022)
        5.3.2 Global Live Vaccines Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Live Vaccines Market Size by Type
        6.1.1 North America Live Vaccines Sales by Type (2017-2028)
        6.1.2 North America Live Vaccines Revenue by Type (2017-2028)
    6.2 North America Live Vaccines Market Size by Application
        6.2.1 North America Live Vaccines Sales by Application (2017-2028)
        6.2.2 North America Live Vaccines Revenue by Application (2017-2028)
    6.3 North America Live Vaccines Market Size by Country
        6.3.1 North America Live Vaccines Sales by Country (2017-2028)
        6.3.2 North America Live Vaccines Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Live Vaccines Market Size by Type
        7.1.1 Europe Live Vaccines Sales by Type (2017-2028)
        7.1.2 Europe Live Vaccines Revenue by Type (2017-2028)
    7.2 Europe Live Vaccines Market Size by Application
        7.2.1 Europe Live Vaccines Sales by Application (2017-2028)
        7.2.2 Europe Live Vaccines Revenue by Application (2017-2028)
    7.3 Europe Live Vaccines Market Size by Country
        7.3.1 Europe Live Vaccines Sales by Country (2017-2028)
        7.3.2 Europe Live Vaccines Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Live Vaccines Market Size by Type
        8.1.1 Asia Pacific Live Vaccines Sales by Type (2017-2028)
        8.1.2 Asia Pacific Live Vaccines Revenue by Type (2017-2028)
    8.2 Asia Pacific Live Vaccines Market Size by Application
        8.2.1 Asia Pacific Live Vaccines Sales by Application (2017-2028)
        8.2.2 Asia Pacific Live Vaccines Revenue by Application (2017-2028)
    8.3 Asia Pacific Live Vaccines Market Size by Region
        8.3.1 Asia Pacific Live Vaccines Sales by Region (2017-2028)
        8.3.2 Asia Pacific Live Vaccines Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Live Vaccines Market Size by Type
        9.1.1 Latin America Live Vaccines Sales by Type (2017-2028)
        9.1.2 Latin America Live Vaccines Revenue by Type (2017-2028)
    9.2 Latin America Live Vaccines Market Size by Application
        9.2.1 Latin America Live Vaccines Sales by Application (2017-2028)
        9.2.2 Latin America Live Vaccines Revenue by Application (2017-2028)
    9.3 Latin America Live Vaccines Market Size by Country
        9.3.1 Latin America Live Vaccines Sales by Country (2017-2028)
        9.3.2 Latin America Live Vaccines Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Live Vaccines Market Size by Type
        10.1.1 Middle East and Africa Live Vaccines Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Live Vaccines Revenue by Type (2017-2028)
    10.2 Middle East and Africa Live Vaccines Market Size by Application
        10.2.1 Middle East and Africa Live Vaccines Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Live Vaccines Revenue by Application (2017-2028)
    10.3 Middle East and Africa Live Vaccines Market Size by Country
        10.3.1 Middle East and Africa Live Vaccines Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Live Vaccines Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Merck
        11.1.1 Merck Corporation Information
        11.1.2 Merck Overview
        11.1.3 Merck Live Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Merck Live Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Merck Recent Developments
    11.2 GlaxoSmithKline
        11.2.1 GlaxoSmithKline Corporation Information
        11.2.2 GlaxoSmithKline Overview
        11.2.3 GlaxoSmithKline Live Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 GlaxoSmithKline Live Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 GlaxoSmithKline Recent Developments
    11.3 Pfizer
        11.3.1 Pfizer Corporation Information
        11.3.2 Pfizer Overview
        11.3.3 Pfizer Live Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Pfizer Live Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Pfizer Recent Developments
    11.4 Novartis
        11.4.1 Novartis Corporation Information
        11.4.2 Novartis Overview
        11.4.3 Novartis Live Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Novartis Live Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Novartis Recent Developments
    11.5 Astellas Pharma
        11.5.1 Astellas Pharma Corporation Information
        11.5.2 Astellas Pharma Overview
        11.5.3 Astellas Pharma Live Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Astellas Pharma Live Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Astellas Pharma Recent Developments
    11.6 Emergent BioSolutions
        11.6.1 Emergent BioSolutions Corporation Information
        11.6.2 Emergent BioSolutions Overview
        11.6.3 Emergent BioSolutions Live Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Emergent BioSolutions Live Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Emergent BioSolutions Recent Developments
    11.7 AstraZeneca
        11.7.1 AstraZeneca Corporation Information
        11.7.2 AstraZeneca Overview
        11.7.3 AstraZeneca Live Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 AstraZeneca Live Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 AstraZeneca Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Live Vaccines Industry Chain Analysis
    12.2 Live Vaccines Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Live Vaccines Production Mode & Process
    12.4 Live Vaccines Sales and Marketing
        12.4.1 Live Vaccines Sales Channels
        12.4.2 Live Vaccines Distributors
    12.5 Live Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Live Vaccines Industry Trends
    13.2 Live Vaccines Market Drivers
    13.3 Live Vaccines Market Challenges
    13.4 Live Vaccines Market Restraints
14 Key Findings in The Global Live Vaccines Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Live Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Monovalent Live Vaccines
    Table 3. Major Manufacturers of Multivalent Live Vaccines
    Table 4. Global Live Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Live Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Live Vaccines Sales by Region (2017-2022) & (K Doses)
    Table 7. Global Live Vaccines Sales Market Share by Region (2017-2022)
    Table 8. Global Live Vaccines Sales by Region (2023-2028) & (K Doses)
    Table 9. Global Live Vaccines Sales Market Share by Region (2023-2028)
    Table 10. Global Live Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Live Vaccines Revenue Market Share by Region (2017-2022)
    Table 12. Global Live Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Live Vaccines Revenue Market Share by Region (2023-2028)
    Table 14. Global Live Vaccines Sales by Manufacturers (2017-2022) & (K Doses)
    Table 15. Global Live Vaccines Sales Share by Manufacturers (2017-2022)
    Table 16. Global Live Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Live Vaccines Revenue Share by Manufacturers (2017-2022)
    Table 18. Live Vaccines Price by Manufacturers (2017-2022) &(USD/Dose)
    Table 19. Global Live Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Live Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live Vaccines as of 2021)
    Table 21. Live Vaccines Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Live Vaccines Product Offered
    Table 23. Date of Manufacturers Enter into Live Vaccines Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Live Vaccines Sales by Type (2017-2022) & (K Doses)
    Table 26. Global Live Vaccines Sales by Type (2023-2028) & (K Doses)
    Table 27. Global Live Vaccines Sales Share by Type (2017-2022)
    Table 28. Global Live Vaccines Sales Share by Type (2023-2028)
    Table 29. Global Live Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Live Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Live Vaccines Revenue Share by Type (2017-2022)
    Table 32. Global Live Vaccines Revenue Share by Type (2023-2028)
    Table 33. Live Vaccines Price by Type (2017-2022) & (USD/Dose)
    Table 34. Global Live Vaccines Price Forecast by Type (2023-2028) & (USD/Dose)
    Table 35. Global Live Vaccines Sales by Application (2017-2022) & (K Doses)
    Table 36. Global Live Vaccines Sales by Application (2023-2028) & (K Doses)
    Table 37. Global Live Vaccines Sales Share by Application (2017-2022)
    Table 38. Global Live Vaccines Sales Share by Application (2023-2028)
    Table 39. Global Live Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Live Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Live Vaccines Revenue Share by Application (2017-2022)
    Table 42. Global Live Vaccines Revenue Share by Application (2023-2028)
    Table 43. Live Vaccines Price by Application (2017-2022) & (USD/Dose)
    Table 44. Global Live Vaccines Price Forecast by Application (2023-2028) & (USD/Dose)
    Table 45. North America Live Vaccines Sales by Type (2017-2022) & (K Doses)
    Table 46. North America Live Vaccines Sales by Type (2023-2028) & (K Doses)
    Table 47. North America Live Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Live Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Live Vaccines Sales by Application (2017-2022) & (K Doses)
    Table 50. North America Live Vaccines Sales by Application (2023-2028) & (K Doses)
    Table 51. North America Live Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Live Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Live Vaccines Sales by Country (2017-2022) & (K Doses)
    Table 54. North America Live Vaccines Sales by Country (2023-2028) & (K Doses)
    Table 55. North America Live Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Live Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Live Vaccines Sales by Type (2017-2022) & (K Doses)
    Table 58. Europe Live Vaccines Sales by Type (2023-2028) & (K Doses)
    Table 59. Europe Live Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Live Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Live Vaccines Sales by Application (2017-2022) & (K Doses)
    Table 62. Europe Live Vaccines Sales by Application (2023-2028) & (K Doses)
    Table 63. Europe Live Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Live Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Live Vaccines Sales by Country (2017-2022) & (K Doses)
    Table 66. Europe Live Vaccines Sales by Country (2023-2028) & (K Doses)
    Table 67. Europe Live Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Live Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Live Vaccines Sales by Type (2017-2022) & (K Doses)
    Table 70. Asia Pacific Live Vaccines Sales by Type (2023-2028) & (K Doses)
    Table 71. Asia Pacific Live Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Live Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Live Vaccines Sales by Application (2017-2022) & (K Doses)
    Table 74. Asia Pacific Live Vaccines Sales by Application (2023-2028) & (K Doses)
    Table 75. Asia Pacific Live Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Live Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Live Vaccines Sales by Region (2017-2022) & (K Doses)
    Table 78. Asia Pacific Live Vaccines Sales by Region (2023-2028) & (K Doses)
    Table 79. Asia Pacific Live Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Live Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Live Vaccines Sales by Type (2017-2022) & (K Doses)
    Table 82. Latin America Live Vaccines Sales by Type (2023-2028) & (K Doses)
    Table 83. Latin America Live Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Live Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Live Vaccines Sales by Application (2017-2022) & (K Doses)
    Table 86. Latin America Live Vaccines Sales by Application (2023-2028) & (K Doses)
    Table 87. Latin America Live Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Live Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Live Vaccines Sales by Country (2017-2022) & (K Doses)
    Table 90. Latin America Live Vaccines Sales by Country (2023-2028) & (K Doses)
    Table 91. Latin America Live Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Live Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Live Vaccines Sales by Type (2017-2022) & (K Doses)
    Table 94. Middle East and Africa Live Vaccines Sales by Type (2023-2028) & (K Doses)
    Table 95. Middle East and Africa Live Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Live Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Live Vaccines Sales by Application (2017-2022) & (K Doses)
    Table 98. Middle East and Africa Live Vaccines Sales by Application (2023-2028) & (K Doses)
    Table 99. Middle East and Africa Live Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Live Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Live Vaccines Sales by Country (2017-2022) & (K Doses)
    Table 102. Middle East and Africa Live Vaccines Sales by Country (2023-2028) & (K Doses)
    Table 103. Middle East and Africa Live Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Live Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Merck Corporation Information
    Table 106. Merck Description and Major Businesses
    Table 107. Merck Live Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 108. Merck Live Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Merck Recent Developments
    Table 110. GlaxoSmithKline Corporation Information
    Table 111. GlaxoSmithKline Description and Major Businesses
    Table 112. GlaxoSmithKline Live Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 113. GlaxoSmithKline Live Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. GlaxoSmithKline Recent Developments
    Table 115. Pfizer Corporation Information
    Table 116. Pfizer Description and Major Businesses
    Table 117. Pfizer Live Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 118. Pfizer Live Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Pfizer Recent Developments
    Table 120. Novartis Corporation Information
    Table 121. Novartis Description and Major Businesses
    Table 122. Novartis Live Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 123. Novartis Live Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Novartis Recent Developments
    Table 125. Astellas Pharma Corporation Information
    Table 126. Astellas Pharma Description and Major Businesses
    Table 127. Astellas Pharma Live Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 128. Astellas Pharma Live Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Astellas Pharma Recent Developments
    Table 130. Emergent BioSolutions Corporation Information
    Table 131. Emergent BioSolutions Description and Major Businesses
    Table 132. Emergent BioSolutions Live Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 133. Emergent BioSolutions Live Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Emergent BioSolutions Recent Developments
    Table 135. AstraZeneca Corporation Information
    Table 136. AstraZeneca Description and Major Businesses
    Table 137. AstraZeneca Live Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 138. AstraZeneca Live Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. AstraZeneca Recent Developments
    Table 140. Key Raw Materials Lists
    Table 141. Raw Materials Key Suppliers Lists
    Table 142. Live Vaccines Distributors List
    Table 143. Live Vaccines Customers List
    Table 144. Live Vaccines Market Trends
    Table 145. Live Vaccines Market Drivers
    Table 146. Live Vaccines Market Challenges
    Table 147. Live Vaccines Market Restraints
    Table 148. Research Programs/Design for This Report
    Table 149. Key Data Information from Secondary Sources
    Table 150. Key Data Information from Primary Sources
List of Figures
    Figure 1. Live Vaccines Product Picture
    Figure 3. Global Live Vaccines Market Share by Type in 2021 & 2028
    Figure 3. Monovalent Live Vaccines Product Picture
    Figure 4. Multivalent Live Vaccines Product Picture
    Figure 5. Global Live Vaccines Market Share by Application in 2021 & 2028
    Figure 6. Adults
    Figure 7. Children
    Figure 8. Live Vaccines Report Years Considered
    Figure 9. Global Live Vaccines Sales 2017-2028 (K Doses)
    Figure 10. Global Live Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Live Vaccines Revenue 2017-2028 (US$ Million)
    Figure 12. Global Live Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 13. Global Live Vaccines Sales Market Share by Region (2017-2022)
    Figure 14. Global Live Vaccines Sales Market Share by Region (2023-2028)
    Figure 15. North America Live Vaccines Sales YoY (2017-2028) & (K Doses)
    Figure 16. North America Live Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 17. Europe Live Vaccines Sales YoY (2017-2028) & (K Doses)
    Figure 18. Europe Live Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Asia-Pacific Live Vaccines Sales YoY (2017-2028) & (K Doses)
    Figure 20. Asia-Pacific Live Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Latin America Live Vaccines Sales YoY (2017-2028) & (K Doses)
    Figure 22. Latin America Live Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Middle East & Africa Live Vaccines Sales YoY (2017-2028) & (K Doses)
    Figure 24. Middle East & Africa Live Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. The Live Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 26. The Top 5 and 10 Largest Manufacturers of Live Vaccines in the World: Market Share by Live Vaccines Revenue in 2021
    Figure 27. Global Live Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 28. Global Live Vaccines Sales Market Share by Type (2017-2028)
    Figure 29. Global Live Vaccines Revenue Market Share by Type (2017-2028)
    Figure 30. Global Live Vaccines Sales Market Share by Application (2017-2028)
    Figure 31. Global Live Vaccines Revenue Market Share by Application (2017-2028)
    Figure 32. North America Live Vaccines Sales Market Share by Type (2017-2028)
    Figure 33. North America Live Vaccines Revenue Market Share by Type (2017-2028)
    Figure 34. North America Live Vaccines Sales Market Share by Application (2017-2028)
    Figure 35. North America Live Vaccines Revenue Market Share by Application (2017-2028)
    Figure 36. North America Live Vaccines Sales Share by Country (2017-2028)
    Figure 37. North America Live Vaccines Revenue Share by Country (2017-2028)
    Figure 38. U.S. Live Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 39. Canada Live Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 40. Europe Live Vaccines Sales Market Share by Type (2017-2028)
    Figure 41. Europe Live Vaccines Revenue Market Share by Type (2017-2028)
    Figure 42. Europe Live Vaccines Sales Market Share by Application (2017-2028)
    Figure 43. Europe Live Vaccines Revenue Market Share by Application (2017-2028)
    Figure 44. Europe Live Vaccines Sales Share by Country (2017-2028)
    Figure 45. Europe Live Vaccines Revenue Share by Country (2017-2028)
    Figure 46. Germany Live Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 47. France Live Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 48. U.K. Live Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 49. Italy Live Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 50. Russia Live Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 51. Asia Pacific Live Vaccines Sales Market Share by Type (2017-2028)
    Figure 52. Asia Pacific Live Vaccines Revenue Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Live Vaccines Sales Market Share by Application (2017-2028)
    Figure 54. Asia Pacific Live Vaccines Revenue Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Live Vaccines Sales Share by Region (2017-2028)
    Figure 56. Asia Pacific Live Vaccines Revenue Share by Region (2017-2028)
    Figure 57. China Live Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 58. Japan Live Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 59. South Korea Live Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 60. India Live Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 61. Australia Live Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 62. Taiwan Live Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 63. Indonesia Live Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 64. Thailand Live Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 65. Malaysia Live Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 66. Philippines Live Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 67. Latin America Live Vaccines Sales Market Share by Type (2017-2028)
    Figure 68. Latin America Live Vaccines Revenue Market Share by Type (2017-2028)
    Figure 69. Latin America Live Vaccines Sales Market Share by Application (2017-2028)
    Figure 70. Latin America Live Vaccines Revenue Market Share by Application (2017-2028)
    Figure 71. Latin America Live Vaccines Sales Share by Country (2017-2028)
    Figure 72. Latin America Live Vaccines Revenue Share by Country (2017-2028)
    Figure 73. Mexico Live Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 74. Brazil Live Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 75. Argentina Live Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 76. Middle East and Africa Live Vaccines Sales Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa Live Vaccines Revenue Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Live Vaccines Sales Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa Live Vaccines Revenue Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Live Vaccines Sales Share by Country (2017-2028)
    Figure 81. Middle East and Africa Live Vaccines Revenue Share by Country (2017-2028)
    Figure 82. Turkey Live Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 83. Saudi Arabia Live Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 84. U.A.E Live Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 85. Live Vaccines Value Chain
    Figure 86. Live Vaccines Production Process
    Figure 87. Channels of Distribution
    Figure 88. Distributors Profiles
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed